CD79A and systemic lupus erythematosus: Therefore, we performed a retrospective chart review of patients with isolated IgA anti-β2GPI and compared their clinical features with individually matched controls to determine whether isolated IgA anti-β2GPI is associated with an increased risk for thromboembolic events, especially within a background of systemic lupus erythematosus (SLE).